![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
The item has been added to your shopping cart.
Home » DOMANTIS SUCCESSFUL IN PATENT OPPOSITION PROCEEDINGS
DOMANTIS SUCCESSFUL IN PATENT OPPOSITION PROCEEDINGS
Domantis Limited, the human Domain Antibody Therapeutics company, has successfully opposed European patent number EP0656946, leading to a major amendment of the main claim in the patent and a significant narrowing of the scope of 34 of the 41 other claims. The decision of the Opposition Division of the European Patent Office (EPO) reaffirms Domantis' complete freedom to operate in the field of human Domain Antibodies.
PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/09-01-2005/0004098496&EDATE=)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct